150 related articles for article (PubMed ID: 19756481)
1. Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease.
Villar E; Polkinghorne KR; Chang SH; Chadban SJ; McDonald SP
Diabetologia; 2009 Dec; 52(12):2536-41. PubMed ID: 19756481
[TBL] [Abstract][Full Text] [Related]
2. Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013.
Koye DN; Magliano DJ; Reid CM; Pavkov ME; Chadban SJ; McDonald SP; Polkinghorne KR; White S; Paul C; Shaw JE
Am J Kidney Dis; 2019 Mar; 73(3):300-308. PubMed ID: 30579709
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.
Lim WH; Johnson DW; Hawley C; Lok C; Polkinghorne KR; Roberts MA; Boudville N; Wong G
Med J Aust; 2018 Nov; 209(10):440-446. PubMed ID: 30332936
[TBL] [Abstract][Full Text] [Related]
4. Changes in excess mortality among adults with diabetes-related end-stage kidney disease: a comparison between the USA and Australia.
Harding JL; Morton JI; Shaw JE; Patzer RE; McDonald SP; Magliano DJ
Nephrol Dial Transplant; 2022 Sep; 37(10):2004-2013. PubMed ID: 34724066
[TBL] [Abstract][Full Text] [Related]
5. The Association Between Age of Onset of Type 2 Diabetes and the Long-term Risk of End-Stage Kidney Disease: A National Registry Study.
Morton JI; Liew D; McDonald SP; Shaw JE; Magliano DJ
Diabetes Care; 2020 Aug; 43(8):1788-1795. PubMed ID: 32540924
[TBL] [Abstract][Full Text] [Related]
6. Kidney failure risk in type 1 vs. type 2 childhood-onset diabetes mellitus.
Pleniceanu O; Twig G; Tzur D; Gruber N; Stern-Zimmer M; Afek A; Erlich T; Keinan-Boker L; Skorecki K; Calderon-Margalit R; Vivante A
Pediatr Nephrol; 2021 Feb; 36(2):333-340. PubMed ID: 32761484
[TBL] [Abstract][Full Text] [Related]
7. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
Villar E; Chang SH; McDonald SP
Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
[TBL] [Abstract][Full Text] [Related]
8. Incident heart failure and the subsequent risk of progression to end stage kidney disease in individuals with type 2 diabetes.
Liu S; Liu JJ; Ang K; Lee J; Chan C; Gurung RL; Zheng H; Tang J; Lim SC
Cardiovasc Diabetol; 2024 Jun; 23(1):204. PubMed ID: 38879473
[TBL] [Abstract][Full Text] [Related]
9. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
10. Excess all-cause and cause-specific mortality for people with diabetes and end-stage kidney disease.
Morton JI; Sacre JW; McDonald SP; Magliano DJ; Shaw JE
Diabet Med; 2022 Jun; 39(6):e14775. PubMed ID: 34951712
[TBL] [Abstract][Full Text] [Related]
11. Absolute risk and risk factors for stroke mortality in patients with end-stage kidney disease (ESKD): population-based cohort study using data linkage.
De La Mata NL; Alfaro-Ramirez M; Kelly PJ; Masson P; Al-Shahi Salman R; Webster AC
BMJ Open; 2019 Feb; 9(2):e026263. PubMed ID: 30798318
[TBL] [Abstract][Full Text] [Related]
12. End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases.
Tang W; Mohandas J; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Wiggins KJ; Bannister KM; Campbell SB; Johnson DW
BMC Nephrol; 2012 Dec; 13():164. PubMed ID: 23206870
[TBL] [Abstract][Full Text] [Related]
13. End-stage kidney disease due to scleroderma--outcomes in 127 consecutive ANZDATA registry cases.
Siva B; McDonald SP; Hawley CM; Rosman JB; Brown FG; Wiggins KJ; Bannister KM; Campbell SB; Johnson DW
Nephrol Dial Transplant; 2011 Oct; 26(10):3165-71. PubMed ID: 21357212
[TBL] [Abstract][Full Text] [Related]
14. Retinopathy progression and the risk of end-stage kidney disease: results from a longitudinal Japanese cohort of 232 patients with type 2 diabetes and biopsy-proven diabetic kidney disease.
Yamanouchi M; Mori M; Hoshino J; Kinowaki K; Fujii T; Ohashi K; Furuichi K; Wada T; Ubara Y
BMJ Open Diabetes Res Care; 2019; 7(1):e000726. PubMed ID: 31798893
[TBL] [Abstract][Full Text] [Related]
15. Incidence and relative risk of renal replacement therapy in people with and without diabetes between 2002 and 2016 in a German region.
Narres M; Claessen H; Kvitkina T; Koch M; Rump LC; Weinreich T; Icks A
Diabetologia; 2020 Mar; 63(3):648-658. PubMed ID: 31865404
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.
Iwai T; Miyazaki M; Yamada G; Nakayama M; Yamamoto T; Satoh M; Sato H; Ito S
Clin Exp Nephrol; 2018 Apr; 22(2):328-336. PubMed ID: 28752289
[TBL] [Abstract][Full Text] [Related]
17. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
Buyadaa O; Magliano DJ; Salim A; Koye DN; Shaw JE
Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
[TBL] [Abstract][Full Text] [Related]
18. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy.
Grace BS; Clayton P; McDonald SP
Nephrology (Carlton); 2012 Jan; 17(1):76-84. PubMed ID: 21854505
[TBL] [Abstract][Full Text] [Related]
19. Trends in the Incidence of End-Stage Kidney Disease in Type 1 and Type 2 Diabetes in Australia, 2010-2019.
Morton JI; Carstensen B; McDonald SP; Polkinghorne KR; Shaw JE; Magliano DJ
Am J Kidney Dis; 2023 Nov; 82(5):608-616. PubMed ID: 37487818
[TBL] [Abstract][Full Text] [Related]
20. Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963-2014).
Fernando MR; Dent H; McDonald SP; Rangan GK
Popul Health Metr; 2017 Feb; 15(1):7. PubMed ID: 28212688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
